Meaning
In vitro bioaccessibility measures the fraction of a chemical migrant that dissolves in fed-state simulated intestinal fluid, indicating the maximum amount available for systemic absorption. The evaluation of fessif bioaccessibility is critical for hydrophobic polymer additives, such as plasticizers and antioxidants, which are ingested via packaged foods. The high concentration of bile salts and fatty acids in the fed state increases the solubility of these lipophilic compounds.
This test provides a realistic estimation of human exposure after a high-fat meal.
Intestinal Dissolution
Surfactant-mediated solubilisation dominates the fed-state simulated environment. High levels of sodium taurocholate and lecithin in the fessif bioaccessibility test create complex mixed micelles and emulsion droplets that efficiently dissolve organic molecules. This represents the postprandial state where lipid digestion products are abundant.
Release Assessment
Exposure calculations rely on these fed-state testing results to avoid overestimating toxicological risks. The fessif bioaccessibility value determines the actual dissolved concentration of a compound in the gut rather than the total amount extracted by harsh solvents. This measurement helps regulators set realistic migration limits for food-contact plastics.
It prevents the unnecessary rejection of safe polymer formulations.
Moulding Influence
Mould processing parameters such as cooling rate and injection pressure indirectly influence the release profile of additives into the gut. Rapid cooling can cause phase separation or uneven distribution of additives within the moulded item, which alters their subsequent migration into food and simulated fluids. If an antioxidant migrates rapidly to the plastic surface due to poor moulding control, its concentration in the digestive simulant rises.
Optimizing the moulding run to achieve a homogeneous distribution of additives limits their migration and maintains safe exposure levels.